Current and historical daily PE Ratio for Pharmaresearch Bio Co Ltd (
XKRX:217950
) from 2015 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Pharmaresearch Bio stock (XKRX:217950) PE ratio as of Jun 20 2024 is 49.21.
More Details
Pharmaresearch Bio Co Ltd (XKRX:217950) PE Ratio (TTM) Chart
Pharmaresearch Bio Co Ltd (XKRX:217950) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 634
- 1
- 2
- 3
- 4
- 5
- 6
- 8
| Pharmaresearch Bio PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-20 | 49.2 | 2024-04-12 | 52.4 |
| 2024-06-19 | 49.2 | 2024-04-11 | 54.4 |
| 2024-06-18 | 50.0 | 2024-04-09 | 54.7 |
| 2024-06-17 | 49.2 | 2024-04-08 | 54.0 |
| 2024-06-14 | 49.2 | 2024-04-05 | 56.1 |
| 2024-06-13 | 49.9 | 2024-04-04 | 56.1 |
| 2024-06-12 | 50.1 | 2024-04-03 | 53.9 |
| 2024-06-11 | 48.3 | 2024-04-02 | 55.1 |
| 2024-06-10 | 47.4 | 2024-04-01 | 55.5 |
| 2024-06-07 | 47.2 | 2024-03-29 | 56.2 |
| 2024-06-05 | 43.6 | 2024-03-28 | 53.5 |
| 2024-06-04 | 43.6 | 2024-03-27 | 52.7 |
| 2024-06-03 | 49.0 | 2024-03-26 | 52.5 |
| 2024-05-31 | 49.0 | 2024-03-25 | 52.5 |
| 2024-05-30 | 48.1 | 2024-03-22 | 51.7 |
| 2024-05-29 | 48.3 | 2024-03-21 | 51.1 |
| 2024-05-28 | 50.4 | 2024-03-20 | 52.7 |
| 2024-05-27 | 49.9 | 2024-03-19 | 53.5 |
| 2024-05-24 | 50.2 | 2024-03-18 | 54.2 |
| 2024-05-23 | 50.9 | 2024-03-15 | 50.6 |
| 2024-05-22 | 52.7 | 2024-03-14 | 49.8 |
| 2024-05-21 | 53.0 | 2024-03-13 | 49.1 |
| 2024-05-20 | 52.7 | 2024-03-12 | 49.0 |
| 2024-05-17 | 52.3 | 2024-03-11 | 49.6 |
| 2024-05-16 | 52.9 | 2024-03-08 | 48.3 |
| 2024-05-14 | 53.4 | 2024-03-07 | 48.1 |
| 2024-05-13 | 53.4 | 2024-03-06 | 48.1 |
| 2024-05-10 | 53.4 | 2024-03-05 | 48.1 |
| 2024-05-09 | 53.3 | 2024-03-04 | 47.1 |
| 2024-05-08 | 52.6 | 2024-02-29 | 45.8 |
| 2024-05-07 | 52.5 | 2024-02-28 | 47.3 |
| 2024-05-03 | 53.3 | 2024-02-27 | 46.2 |
| 2024-05-02 | 52.3 | 2024-02-26 | 48.3 |
| 2024-04-30 | 54.5 | 2024-02-23 | 47.4 |
| 2024-04-29 | 55.3 | 2024-02-22 | 48.1 |
| 2024-04-26 | 52.6 | 2024-02-21 | 48.8 |
| 2024-04-25 | 52.6 | 2024-02-20 | 48.7 |
| 2024-04-24 | 52.7 | 2024-02-19 | 48.8 |
| 2024-04-23 | 52.3 | 2024-02-16 | 48.8 |
| 2024-04-22 | 52.0 | 2024-02-15 | 47.5 |
| 2024-04-19 | 51.4 | 2024-02-14 | 50.3 |
| 2024-04-18 | 52.6 | 2024-02-13 | 50.3 |
| 2024-04-17 | 52.4 | 2024-02-08 | 52.8 |
| 2024-04-16 | 52.5 | 2024-02-07 | 52.2 |
| 2024-04-15 | 52.4 | 2024-02-06 | 50.1 |
Pharmaresearch Bio Co Ltd (XKRX:217950) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Pharmaresearch Bio Co Ltd
ISIN : KR7217950005
Compare
Compare
Traded in other countries / regions
217950.Korea IPO Date
2015-11-05Description
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers